Gregory Christopherson(MedTech FAWG Co-Lead)

Greg Christopherson is the Vice President of Medical Affairs for Medline Industries, a privately-owned manufacturer and distributor of medical devices and supplies devoted to the continuum of healthcare. His current role oversees creation and execution of a comprehensive clinical strategy for the company, encompassing: identification of business and regulatory needs (Clinical Affairs), study design and execution (Clinical Operations), communication of clinical results and publication tactics (Medical Communications) and development of clinical research partners, medical education initiatives and coordination of Medical Science Liaisons (Clinical Development). Prior to joining Medline, Greg served in a scientific affairs capacity for the medical aesthetics division of Allergan, coordinating R&D efforts to commercially support new product launches and the existing device portfolio for breast implants and acellular dermal matrices. He played a key collaborative role internally, integrating divisions across the company (Regulatory, Sales & Marketing, Medical Affairs, R&D) to define and execute research strategy, as well as acting as the primary scientist for KOL engagement and medical education. His previous experience is heavily centered in R&D, as a postdoctoral fellow in the NIH examining the pathophysiology of heterotopic ossification in blast-injured soldiers at Walter Reed, and as a senior scientist at LifeCell, creating novel tissue-based devices for colorectal and wound healing applications. He received his B.S. in Biomedical Engineering from Michigan Technological University, and his M.S. and Ph.D. in Materials Science & Engineering from Johns Hopkins University.